资讯

An explosion at a pharmaceutical factory near Hyderabad has left at least 12 people dead and dozens more injured. India's ...
To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...
Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...
加利福尼亚州诺瓦托 - 市值35亿美元、过去十二个月收入增长33%的生物制药公司Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE )周五宣布,其安格曼综合征治疗药物GTX-102(apazunersen)已获得美国食品药品监督管理局(FDA)的突破性疗法认定。根据 InvestingPro 分析,该公司目前的交易价格低于其公允价值,这表明投资者可能有上涨空间 ...
Investing.com -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE )股价盘前上涨2.2%,此前该公司宣布其用于治疗安格尔曼综合征的实验性药物获得美国食品药品监督管理局 (FDA)的突破性疗法认定。
"Over the past 16 years, Tsinghua University and Bayer have forged a trusted and synergistic partnership that has ...